These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9295115)

  • 21. Recovery of nucleus basalis cholinergic neurons by grafting NGF secretor fibroblasts.
    Piccardo P; Maysinger D; Cuello AC
    Neuroreport; 1992 Apr; 3(4):353-6. PubMed ID: 1515595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of cholinergic deafferentation and NGF on brain electrical coherence.
    Holschneider DP; Leuchter AF; Scremin OU; Treiman DM; Walton NY
    Brain Res Bull; 1998 Mar; 45(5):531-41. PubMed ID: 9570724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Partial reversal of lesion-induced deficits in cortical cholinergic markers by nerve growth factor.
    Haroutunian V; Kanof PD; Davis KL
    Brain Res; 1986 Oct; 386(1-2):397-9. PubMed ID: 3779417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cholinergic marker deficits induced by lesions of the nucleus basalis of Meynert are attenuated by nerve growth factor in young, but not in aged, F344 rats.
    Santucci AC; Kanof PD; Haroutunian V
    Brain Res; 1993 Apr; 609(1-2):327-32. PubMed ID: 8508314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nerve growth factor in Alzheimer's disease: increased levels throughout the brain coupled with declines in nucleus basalis.
    Scott SA; Mufson EJ; Weingartner JA; Skau KA; Crutcher KA
    J Neurosci; 1995 Sep; 15(9):6213-21. PubMed ID: 7666203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological characterization of nerve growth factor and/or monosialoganglioside GM1 effects on cholinergic markers in the adult lesioned brain.
    Garofalo L; Cuello AC
    J Pharmacol Exp Ther; 1995 Feb; 272(2):527-45. PubMed ID: 7853166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of delayed treatment with nerve growth factor on choline acetyltransferase activity in the cortex of rats with lesions of the nucleus basalis magnocellularis: dose requirements.
    Dekker AJ; Thal LJ
    Brain Res; 1992 Jul; 584(1-2):55-63. PubMed ID: 1515953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential alterations of cortical cholinergic and neurotensin markers following ibotenic acid lesions of the nucleus basalis magnocellularis.
    Lapchak PA; Araujo DM; Pasinetti G; Hefti F
    Brain Res; 1993 Jun; 613(2):239-46. PubMed ID: 8186970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spatial learning in rats: correlation with cortical choline acetyltransferase and improvement with NGF following NBM damage.
    Mandel RJ; Gage FH; Thal LJ
    Exp Neurol; 1989 Jun; 104(3):208-17. PubMed ID: 2721623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential modulation of the cholinergic phenotype of the nucleus basalis magnocellularis neurons by applying NGF at the cell body or cortical terminal fields.
    Hu L; Côté SL; Cuello AC
    Exp Neurol; 1997 Jan; 143(1):162-71. PubMed ID: 9000455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of nerve growth factor and GM1 ganglioside on the number and size of cholinergic neurons in rats with unilateral lesion of the nucleus basalis.
    Casamenti F; Di Patre PL; Milan F; Petrelli L; Pepeu G
    Neurosci Lett; 1989 Aug; 103(1):87-91. PubMed ID: 2779858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quisqualic acid-induced lesion of the nucleus basalis of Meynert in young and aging rats: plasticity of surviving NGF receptor-positive cholinergic neurons.
    Unger JW; Schmidt Y
    Exp Neurol; 1992 Sep; 117(3):269-77. PubMed ID: 1397163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microencapsulated nerve growth factor: effects on the forebrain neurons following devascularizing cortical lesions.
    Maysinger D; Jalsenjak I; Cuello AC
    Neurosci Lett; 1992 Jun; 140(1):71-4. PubMed ID: 1407703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cholinergic control of nerve growth factor in adult rats: evidence from cortical cholinergic deafferentation and chronic drug treatment.
    Rossner S; Wörtwein G; Gu Z; Yu J; Schliebs R; Bigl V; Perez-Polo JR
    J Neurochem; 1997 Sep; 69(3):947-53. PubMed ID: 9282916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of intracranial infusions of colchicine and ibotenic acid as models of neurodegeneration in the basal forebrain.
    Shaughnessy LW; Barone S; Mundy WR; Herr DW; Tilson HA
    Brain Res; 1994 Feb; 637(1-2):15-26. PubMed ID: 8180792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microanatomical and electrophysiological changes of the rat dentate gyrus caused by lesions of the nucleus basalis magnocellularis.
    Panocka I; Sagratella S; Scotti de Carolis A; Zeng YC; Amenta F
    Neurosci Lett; 1995 May; 190(3):207-11. PubMed ID: 7637894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does senile impairment of cholinergic system in rats concern only disturbances in cholinergic phenotype or the progressive degeneration of neuronal cell bodies?
    Niewiadomska G; Wyrzykowska J; Chechłacz M
    Acta Biochim Pol; 2000; 47(2):313-30. PubMed ID: 11051196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recovery of neocortical choline acetyltransferase activity following ibotenic acid injection into the nucleus basalis of Meynert in rats.
    Wenk GL; Olton DS
    Brain Res; 1984 Feb; 293(1):184-6. PubMed ID: 6704718
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of THA on passive avoidance retention performance of intact, nucleus basalis, frontal cortex and nucleus basalis + frontal cortex-lesioned rats.
    Riekkinen P; Sirviö J; Riekkinen M; Riekkinen P
    Pharmacol Biochem Behav; 1991 Aug; 39(4):841-6. PubMed ID: 1763101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of nerve growth factor treatment on rats with lesions of the nucleus basalis magnocellularis produced by ibotenic acid, quisqualic acid, and AMPA.
    Winkler J; Thal LJ
    Exp Neurol; 1995 Dec; 136(2):234-50. PubMed ID: 7498413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.